Feng Q, Shan X, Yau V, Cai Z, Xie S
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861125
PMC: 11769033.
DOI: 10.3390/ph18010062.
Ying H, Kimmelman A, Bardeesy N, Kalluri R, Maitra A, DePinho R
Genes Dev. 2024; 39(1-2):36-63.
PMID: 39510840
PMC: 11789498.
DOI: 10.1101/gad.351863.124.
Hu J, Wang J, Guo X, Fan Q, Li X, Li K
Heliyon. 2024; 10(8):e29210.
PMID: 38628720
PMC: 11019237.
DOI: 10.1016/j.heliyon.2024.e29210.
Uehara M, Domoto T, Takenaka S, Takeuchi O, Shimasaki T, Miyashita T
Cancer Drug Resist. 2024; 7:4.
PMID: 38318525
PMC: 10838383.
DOI: 10.20517/cdr.2023.84.
Jung J, Han H
Heliyon. 2024; 10(2):e24463.
PMID: 38298643
PMC: 10828710.
DOI: 10.1016/j.heliyon.2024.e24463.
Association of ACP5 with the tumor immune microenvironment and its role in cell proliferation and metastasis in pancreatic cancer.
Shen J, Shi M, Song A, Ming Y, Zhu X, Ruan Y
Am J Transl Res. 2023; 15(11):6437-6450.
PMID: 38074824
PMC: 10703664.
The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice.
Zhang Y, Zheng F, Wang F, Liu X, Xiang C, Fu S
Biomedicines. 2023; 11(11).
PMID: 38001963
PMC: 10669313.
DOI: 10.3390/biomedicines11112962.
Targeting the Cancer-Neuronal Crosstalk in the Pancreatic Cancer Microenvironment.
Capodanno Y, Hirth M
Int J Mol Sci. 2023; 24(19).
PMID: 37834436
PMC: 10573820.
DOI: 10.3390/ijms241914989.
Stromal cells in the tumor microenvironment: accomplices of tumor progression?.
Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q
Cell Death Dis. 2023; 14(9):587.
PMID: 37666813
PMC: 10477351.
DOI: 10.1038/s41419-023-06110-6.
The role of TGF-β in the tumor microenvironment of pancreatic cancer.
Luo Q, Hu Z, Zhao H, Fan Y, Tu X, Wang Y
Genes Dis. 2023; 10(4):1513-1524.
PMID: 37397548
PMC: 10311106.
DOI: 10.1016/j.gendis.2022.10.019.
Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer.
Chen J, Liu Z, Wu Z, Li W, Tan X
Front Oncol. 2023; 13:1132424.
PMID: 37251940
PMC: 10213255.
DOI: 10.3389/fonc.2023.1132424.
NADPH oxidase 1 in chronic pancreatitis-activated pancreatic stellate cells facilitates the progression of pancreatic cancer.
Chakraborty A, Halder B, Mondal S, Barrett A, Zhi W, Csanyi G
Am J Cancer Res. 2023; 13(1):118-142.
PMID: 36777508
PMC: 9906081.
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer.
Kiemen A, Damanakis A, Braxton A, He J, Laheru D, Fishman E
Med. 2023; 4(2):75-91.
PMID: 36773599
PMC: 9922376.
DOI: 10.1016/j.medj.2022.11.009.
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment.
Tanaka H, Nakazawa T, Enomoto A, Masamune A, Kano M
Cancers (Basel). 2023; 15(3).
PMID: 36765684
PMC: 9913712.
DOI: 10.3390/cancers15030724.
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer.
Falcomata C, Barthel S, Schneider G, Rad R, Schmidt-Supprian M, Saur D
Cancer Discov. 2023; 13(2):278-297.
PMID: 36622087
PMC: 9900325.
DOI: 10.1158/2159-8290.CD-22-0876.
The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K
Cancer Sci. 2022; 114(1):16-24.
PMID: 36197901
PMC: 9807521.
DOI: 10.1111/cas.15609.
CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming.
Lu X, Wu Y, Cao R, Yu X, Gong J
Anim Cells Syst (Seoul). 2022; 26(4):148-157.
PMID: 36046033
PMC: 9423839.
DOI: 10.1080/19768354.2022.2091019.
Increased Stiffness Downregulates Focal Adhesion Kinase Expression in Pancreatic Cancer Cells Cultured in 3D Self-Assembling Peptide Scaffolds.
Betriu N, Andreeva A, Alonso A, Semino C
Biomedicines. 2022; 10(8).
PMID: 36009384
PMC: 9405295.
DOI: 10.3390/biomedicines10081835.
P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Xue R, Zhou J, Wu J, Meng Q, Gong J, Shen L
Dig Dis Sci. 2022; 68(4):1339-1350.
PMID: 36002675
DOI: 10.1007/s10620-022-07605-6.
Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression.
Chong Y, Peter E, Lee F, Chan C, Chai S, Ling L
Sci Rep. 2022; 12(1):12315.
PMID: 35853996
PMC: 9296552.
DOI: 10.1038/s41598-022-16671-9.